Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Sclerosing Cholangitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Primary Sclerosing Cholangitis with Ulcerative Colitis
Journal:
The Tohoku journal of experimental medicine
Treatment Used:
Ursodeoxycholic Acid
Number of Patients:
1
Published —
February 08, 2021
This case report describes an 11-year-old girl diagnosed with ulcerative colitis who developed primary sclerosing cholangitis (bile duct inflammation) treated with ursodeoxycholic acid.
Condition:
Cholangiocarcinoma
Journal:
The Journal of international medical research
Treatment Used:
Prednisolone, Teprenone, Potassium Chloride, and Calcium Carbonate
Number of Patients:
1
Published —
October 07, 2020
The study researched a case of cholangiocarcinoma.
Condition:
Children and Adults with Primary Sclerosing Cholangitis (PSC)
Journal:
Scandinavian journal of gastroenterology
Treatment Used:
Oral Vancomycin (OV)
Number of Patients:
0
Published —
July 08, 2020
This study reported the long-term biochemical course and outcomes of patients with primary sclerosing cholangitis (inflamed bile duct; PSC) treated with oral vancomycin (OV).
Condition:
Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC)
Journal:
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Treatment Used:
Ursodeoxycholic acid or Obeticholic Acid
Number of Patients:
0
Published —
May 26, 2020
This article discusses the diagnosis and treatment of primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) immune-mediated chronic liver diseases.
Condition:
IgG4-related Sclerosing Cholangitis
Journal:
PloS one
Treatment Used:
Endoscopic Biliary Drainage (EBD) and Corticosteroid (CS)
Number of Patients:
69
Published —
May 01, 2020
This study aimed to determine the best treatment approach, effectiveness, and safety for patients with IgG4-related sclerosing cholangitis (ISC) using endoscopic biliary drainage (EBD) and corticosteroid (CS).
Condition:
Pouchitis in Inflammatory Bowel Disease
Journal:
Arquivos de gastroenterologia
Treatment Used:
Antibiotics, Probiotics, Thiopurine, and Biological Therapy
Number of Patients:
0
Published —
April 16, 2020
This article discusses the treatment of pouchitis in patients with inflammatory bowel disease.
Condition:
Primary Sclerosing Cholangitis (PSC)
Journal:
Journal of gastroenterology
Treatment Used:
Ursodeoxycholic Acid (UDCA)
Number of Patients:
0
Published —
March 31, 2020
This article evaluates emerging treatment strategies for primary sclerosing cholangitis (PSC), a primary progressive liver disease.
Condition:
Primary Sclerosing Cholangitis
Journal:
United European gastroenterology journal
Treatment Used:
Diclofenac
Number of Patients:
931
Published —
March 28, 2020
The study researched the use of Diclofenac in preventing primary sclerosing cholangitis.
Condition:
Sclerosing Cholangitis
Journal:
Scandinavian journal of gastroenterology
Treatment Used:
Liver Transplantation
Number of Patients:
48
Published —
March 20, 2020
In this study, researchers evaluated the outcomes of undergoing liver transplantation for the treatment of sclerosing cholangitis.
Condition:
Primary Sclerosing Cholangitis (PSC)
Journal:
Journal of hepatology
Treatment Used:
Obeticholic Acid (OCA)
Number of Patients:
76
Published —
March 14, 2020
This study investigated the safety and effectiveness of obeticholic acid (OCA) in the treatment of primary sclerosing cholangitis (liver disease; PSC).
Condition:
Autoimmune Hepatitis (AIH)
Journal:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Treatment Used:
Liver Transplantation (LT)
Number of Patients:
30970
Published —
March 01, 2020
This study analyzed long-term patient and graft survival after liver transplantation for autoimmune hepatitis (AIH-LT).
Condition:
Primary Sclerosing Cholangitis (PSC)
Journal:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Treatment Used:
Tumor Necrosis Factor (TNF) Antagonists
Number of Patients:
141
Published —
February 19, 2020
This study evaluated the effects of tumor necrosis factor (TNF) antagonists (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events) in patients with primary sclerosing cholangitis (chronic disease in which the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked; PSC).
Showing 1-12 of 34
Next